Skip to main content
OpenTrials

Clinical trial condition

Malformations of Cortical Development, Group I

Explore clinical trials studying Malformations of Cortical Development, Group I. Study availability and eligibility vary by location and protocol.

123 public trials 31 recruiting studies
Refine in advanced search Browse all conditions

Malformations of Cortical Development, Group I trial results

Active, Not Recruiting

Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution

NCT05044819

Conditions
Brain Diseases, Central Nervous System Diseases, Congenital Abnormalities, +27 more
Locations
  • Clinical Trial Site Little Rock, Arkansas, United States
  • Clinical Trial Site Downey, California, United States
  • Clinical Trial Site Long Beach, California, United States
  • Clinical Trial Site Sacramento, California, United States
View all 26 locations
View Trial Details
Active, Not Recruiting

A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML)

NCT05252585

Conditions
Angiomyolipoma, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +18 more
Locations
  • Novartis Investigative Site Taichung, Taiwan ROC, Taiwan
  • Novartis Investigative Site Taoyuan, Taiwan ROC, Taiwan
  • Novartis Investigative Site Taipei, Taiwan
  • Novartis Investigative Site Taoyuan, Taiwan
View Trial Details
Active, Not Recruiting

Epidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an Observational Study in ITALY

NCT05485831

Conditions
Brain Diseases, Central Nervous System Diseases, Congenital Abnormalities, +25 more
Locations
  • Policlinico Sant'Orsola di Bologna Bologna, Italy
  • NPI AOU Mater Domini Università Magna Graecia Catanzaro, Italy
  • Università degli studi "G. D'annunzio" Chieti Chieti, Italy
  • Azienda Ospedaliera Universitaria Meyer Neurologia Pediatrica Florence, Italy
View all 18 locations
View Trial Details
Active, Not Recruiting

Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued Treatment

NCT02962414

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +17 more
Locations
  • TGen APNNA Phoenix, Arizona, United States
  • David Geffen School of Medicine at UCLA Los Angeles, California, United States
  • UCSF Benioff Children s Hospital Oakland, California, United States
  • Rady Children s Hospital San Diego, California, United States
View all 68 locations
View Trial Details
Active, Not Recruiting

Astroscape: A Study of Radiprodil on Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms in Patients With TSC or FCD Type II

NCT06392009

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Focal Cortical Dysplasia, +14 more
Locations
  • Queensland Children Hospital South Brisbane, Australia
  • University Hospitals Leuven, Pediatric Neurology Leuven, Belgium
  • Alberta Children's Hospital Calgary, Canada
  • The Hospital for Sick Children (Sick Kids) Toronto, Canada
View all 18 locations
View Trial Details

Related conditions